Puma Biotechnology (PBYI) FCF Margin (2017 - 2026)
Puma Biotechnology (PBYI) reported FCF Margin of 2.87% for Q2 2026, down 23.94 percentage points from 26.82% a year earlier and down 31.53 percentage points from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) FCF Margin (2017 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Puma Biotechnology's FCF Margin came in at 17.80%, down 0.78 percentage points year-over-year; for FY2025, it was 18.27%, up 1.41 percentage points from FY2024.
- FCF Margin has increased for three consecutive years, with a five-year change of +17.95 percentage points (FY2020 to FY2025).
- By year, FCF Margin came in at 16.86% in FY2024 (+5.46 pp), 11.40% in FY2023 (+18.34 pp), -6.94% in FY2022 (-15.10 pp) and 8.16% in FY2021 (+7.83 pp).
- The Q2 2026 figure ranks as the lowest quarterly FCF Margin since Q2 2024.
- Year over year, FCF Margin gained in four of the last eight quarters, with an average year-over-year change of +1.63 percentage points.
- The high point for year-over-year FCF Margin in five years was Q1 2023 (a gain of 63.81 percentage points); the low point was Q1 2022 (a drop of 74.76 percentage points).
- Per Business Quant data, the three quarters before Q2 2026 came in at 34.40% (Q1 2026), 19.14% (Q4 2025) and 17.77% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 33.69% |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 25.03% |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 41.97% |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 30.51% |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 52.85% |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 35.25% |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 57.81% |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 28.96% |
| 10 | Puma Biotechnology | 420.82 Mn | 19.27 Mn | 39.86 Mn | 26.48% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 26.48% |
| Jun 30, 2026 | 2.87% |
| Mar 31, 2026 | 34.40% |
| Dec 31, 2025 | 19.16% |
| Sep 30, 2025 | 17.74% |
| Jun 30, 2025 | 26.82% |
| Mar 31, 2025 | 7.72% |
| Dec 31, 2024 | 26.39% |
| Sep 30, 2024 | 13.68% |
| Jun 30, 2024 | 2.14% |
| Mar 31, 2024 | 25.70% |
| Dec 31, 2023 | 14.42% |
| Sep 30, 2023 | 18.87% |
| Jun 30, 2023 | 6.04% |
| Mar 31, 2023 | 5.01% |
| Dec 31, 2022 | 11.70% |
| Sep 30, 2022 | 30.22% |
| Jun 30, 2022 | -23.31% |
| Mar 31, 2022 | -58.80% |
| Dec 31, 2021 | -9.82% |
API Access
Puma Biotechnology FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();